Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001641172-25-008440
Filing Date
2025-05-02
Accepted
2025-05-02 17:35:16
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D/A  
1 primary_doc.xml SCHEDULE 13D/A 13123
  Complete submission text file 0001641172-25-008440.txt   15155
Mailing Address 501 MERRITT 7 NORWALK CT 06851
Business Address 501 MERRITT 7 NORWALK CT 06851 800 997 3337
REED'S, INC. (Subject) CIK: 0001140215 (see all company filings)

EIN.: 352177773 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-84925 | Film No.: 25910233
SIC: 2086 Bottled & Canned Soft Drinks & Carbonated Waters
(CF Office: 04 Manufacturing)

Mailing Address UNIT 8,3/F., QWOMAR TRADING COMPLEX, BLACKBURNE ROAD, PORT PURCELL, ROAD TOWN TORTOLA D8 VG1110
Business Address UNIT 8,3/F., QWOMAR TRADING COMPLEX, BLACKBURNE ROAD, PORT PURCELL, ROAD TOWN TORTOLA D8 VG1110 646-656-8327
Era Regenerative Medicine Ltd (Filed by) CIK: 0002053961 (see all company filings)

EIN.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: SCHEDULE 13D/A